Event

Webinar – California Bridge: Treatment Of Opioid Use In Acute Care

This webinar will discuss ways in which general acute care hospitals can combat the opioid epidemic. Every year, more patients with opioid use disorder visit the ED and are admitted to the hospital. Through the California Bridge Program, hospitals offer rapid access, low barrier buprenorphine starts to treat withdrawal and link patients to long term treatment. This model allows the patients who are already in the hospital, but not in addiction treatment, to be efficiently started on lifesaving treatment. In this webinar, Dr. Snyder will describe the simple steps the EDs and medical/surgical units can take to treat patients with opioid use disorder.

Objectives

  • Understand the importance of starting opioid use disorder treatment in acute care settings
  • Name the steps needed to start buprenorphine in the ED
  • Name the steps needed to start buprenorphine or methadone in med surgical units
  • Articulate a plan for your hospital to improve linkage of patients with opioid use disorder to lifesaving treatment

Registration

Click here for recording and here for slides.

Speakers


Hannah Snyder, MD

Principal Investigator, SHOUT
Assistant Professor, Dept. of Family & Community Medicine
UCSF at Zuckerberg San Francisco General 

Dr. Hannah Snyder practices primary care and addiction medicine at Zuckerberg San Francisco General Hospital. She is a Clinical Assistant Professor in the Department of Family and Community Medicine at the University of California San Francisco. She is a Principal Investigator of the California Bridge Program, which  supports acute care hospitals in offering low barrier buprenorphine starts and linkage to ongoing treatment.